Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.33 USD | +6.52% | +19.62% | +12.74% |
May. 02 | Transcript : Castle Biosciences, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (CSTL) CASTLE BIOSCIENCES Posts Q1 Revenue $73M, vs. Street Est of $66.2M | MT |
Evolution of the average Target Price on Castle Biosciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Castle Biosciences, Inc.
Guggenheim | |
KeyBanc Capital Markets | |
BTIG | |
Canaccord Genuity | |
Scotiabank | |
SVB Securities LLC | |
Lake Street | |
Baird | |
Stephens Inc. | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- CSTL Stock
- Consensus Castle Biosciences, Inc.